Cargando…
Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. I...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403443/ https://www.ncbi.nlm.nih.gov/pubmed/32850884 http://dx.doi.org/10.3389/fmed.2020.00361 |
_version_ | 1783566943685443584 |
---|---|
author | Jiang, Xiaofan Zheng, Juan Zhang, Shixiu Wang, Baozhen Wu, Chaodong Guo, Xin |
author_facet | Jiang, Xiaofan Zheng, Juan Zhang, Shixiu Wang, Baozhen Wu, Chaodong Guo, Xin |
author_sort | Jiang, Xiaofan |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. In particular, microbiota alter intestine absorption of nutrients and intestine permeability, whose dysregulation enhances the delivery of nutrients, endotoxin, and microbiota metabolites to the liver and exacerbates hepatic fat deposition and inflammation. While how altered composition of gut microbiota attributes to NAFLD remains to be elucidated, microbiota metabolites are shown to be involved in the regulation of hepatocyte fat metabolism and liver inflammatory responses. In addition, intestinal microbes and circadian coordinately adjust metabolic regulation in different stages of life. During aging, altered composition of gut microbiota, along with circadian clock dysregulation, appears to contribute to increased incidence and/or severity of NAFLD. |
format | Online Article Text |
id | pubmed-7403443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74034432020-08-25 Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD Jiang, Xiaofan Zheng, Juan Zhang, Shixiu Wang, Baozhen Wu, Chaodong Guo, Xin Front Med (Lausanne) Medicine Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and progresses to non-steatohepatitis (NASH) when the liver displays overt inflammatory damage. Increasing evidence has implicated critical roles for dysbiosis and microbiota-host interactions in NAFLD pathophysiology. In particular, microbiota alter intestine absorption of nutrients and intestine permeability, whose dysregulation enhances the delivery of nutrients, endotoxin, and microbiota metabolites to the liver and exacerbates hepatic fat deposition and inflammation. While how altered composition of gut microbiota attributes to NAFLD remains to be elucidated, microbiota metabolites are shown to be involved in the regulation of hepatocyte fat metabolism and liver inflammatory responses. In addition, intestinal microbes and circadian coordinately adjust metabolic regulation in different stages of life. During aging, altered composition of gut microbiota, along with circadian clock dysregulation, appears to contribute to increased incidence and/or severity of NAFLD. Frontiers Media S.A. 2020-07-29 /pmc/articles/PMC7403443/ /pubmed/32850884 http://dx.doi.org/10.3389/fmed.2020.00361 Text en Copyright © 2020 Jiang, Zheng, Zhang, Wang, Wu and Guo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Jiang, Xiaofan Zheng, Juan Zhang, Shixiu Wang, Baozhen Wu, Chaodong Guo, Xin Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD |
title | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD |
title_full | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD |
title_fullStr | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD |
title_full_unstemmed | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD |
title_short | Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD |
title_sort | advances in the involvement of gut microbiota in pathophysiology of nafld |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403443/ https://www.ncbi.nlm.nih.gov/pubmed/32850884 http://dx.doi.org/10.3389/fmed.2020.00361 |
work_keys_str_mv | AT jiangxiaofan advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld AT zhengjuan advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld AT zhangshixiu advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld AT wangbaozhen advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld AT wuchaodong advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld AT guoxin advancesintheinvolvementofgutmicrobiotainpathophysiologyofnafld |